Cinacalcet Study to Reach Kidney Disease Outcomes Quality Initiative (K/DOQI) Levels
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to observe the effects of a treatment strategy that incorporates
cinacalcet HCl into the management of secondary hyperparathyroidism (HPT) to K/DOQI
recommended targets in subjects with end stage renal disease (ESRD) receiving hemodialysis,
on bio-intact parathyroid hormone, corrected serum calcium, serum phosphorus, and calcium
phosphorus product.